Pharma Journalist -

Xcell Biosciences initiates to accelerate its goal by considering new market opportunities in immunotherapy drug research and development. It has exhibited excellence in new…
Read More...

Clinical stage biopharmaceutical company into discovering and developing Pentarins which is a new class of potent and selective cancer medicines announced the appointment of Brian…
Read More...

AvantGen collaborates with Tanabe Research Laboratories for successful completion of first cancer therapeutic antibody discovery program. AvantGen is accountable for producing novel…
Read More...

U.S.-based multi platform gene therapy company pronounces completion of merger with Inotek pharmaceuticals that looks to combat rare diseases. The inclusive company to emphasize on…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Committed to developing and commercialising products to cure rare diseases proclaims granting US patent entitled Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis.…
Read More...

PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine. As per the…
Read More...

Indivior declares collaboration with Addex Pharma to accelerate GABAB positive allosteric modulators (PAMs). It has previously recorded preclinical efficacy in animal models for alcohol…
Read More...

Taiwan and US based biopharmaceutical company, Foresee pharmaceutical Co., Ltd. ventures into an exclusive license and distribution agreement with an Israel based biopharmaceutical…
Read More...

U.S FDA has accepted the IND application for ASN007, a selective ERK ½ inhibitor as declared by Asana BioSciences which specialises in oncology nd a clinical stage biopharmaceutical…
Read More...